Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML
Condition: Acute Myeloid Leukemia (AML) Interventions: Drug: Pevonedistat; Procedure: transplant; Drug: Azacitidine Sponsors: Milton S. Hershey Medical Center; Millennium Pharmaceuticals, Inc.; Takeda Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials